title: Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
authors.forename: Y
authors.initials: Y
authors.lastname: Bastion
authors.forename: B
authors.initials: B
authors.lastname: Coiffier
authors.forename: C
authors.initials: C
authors.lastname: Dumontet
authors.forename: D
authors.initials: D
authors.lastname: Espinouse
authors.forename: P A
authors.initials: PA
authors.lastname: Bryon
mesh_terms: D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000150:complications; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine